168 related articles for article (PubMed ID: 36977426)
1. Cystinosis.
Hohenfellner K; Zerell K; Haffner D
Klin Monbl Augenheilkd; 2023 Mar; 240(3):251-259. PubMed ID: 36977426
[TBL] [Abstract][Full Text] [Related]
2. Nephropathic cystinosis: an update on genetic conditioning.
Topaloglu R
Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term cysteamine treatment in patients with cystinosis.
Ariceta G; Giordano V; Santos F
Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
Hector E; Cairns D; Michael Wall G
Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
[TBL] [Abstract][Full Text] [Related]
5. Cystinosis: a review.
Elmonem MA; Veys KR; Soliman NA; van Dyck M; van den Heuvel LP; Levtchenko E
Orphanet J Rare Dis; 2016 Apr; 11():47. PubMed ID: 27102039
[TBL] [Abstract][Full Text] [Related]
6. Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis.
Hollywood JA; Kallingappa PK; Cheung PY; Martis RM; Sreebhavan S; 'Atiola RD; Chatterjee A; Buckels EJ; Matthews BG; Lewis PM; Davidson AJ
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F156-F170. PubMed ID: 35695380
[TBL] [Abstract][Full Text] [Related]
7. Cystinosis: clinical presentation, pathogenesis and treatment.
Ivanova E; De Leo MG; De Matteis MA; Levtchenko E
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():176-84. PubMed ID: 25345100
[TBL] [Abstract][Full Text] [Related]
8. [Cystinosis: From the gene identification to the first gene therapy clinical trial].
Cherqui S
Med Sci (Paris); 2023 Mar; 39(3):253-261. PubMed ID: 36943122
[TBL] [Abstract][Full Text] [Related]
9. [Cystinosis : Diagnosis, cystine-depleting therapy, and transition].
Kaufeld J; Weber LT; Kurschat C; Canaan-Kuehl S; Brand E; Oh J; Pape L
Internist (Berl); 2018 Aug; 59(8):861-867. PubMed ID: 29671012
[TBL] [Abstract][Full Text] [Related]
10. [From gene to disease: cystinosis].
Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893
[TBL] [Abstract][Full Text] [Related]
11. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
[TBL] [Abstract][Full Text] [Related]
12. Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivity.
Nicoletti T; Bink A; Helmchen B; Briel N; Frontzek K; Vlad B; Gaspert A; Boudriot E; Jung HH; Reuss AM; Weller M; Hortobágyi T
J Neurol Sci; 2024 Jan; 456():122841. PubMed ID: 38101161
[TBL] [Abstract][Full Text] [Related]
13. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM
J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276
[TBL] [Abstract][Full Text] [Related]
14. Extrarenal complications of cystinosis.
Topaloglu R
Pediatr Nephrol; 2024 Aug; 39(8):2283-2292. PubMed ID: 38127152
[TBL] [Abstract][Full Text] [Related]
15. Cystinosis: Status of research and treatment in India and the world.
Vashist N; Deshpande AA; Kanakaraj A; Ravichandran R; Bachhawat AK
J Biosci; 2023; 48():. PubMed ID: 38018544
[TBL] [Abstract][Full Text] [Related]
16. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report.
Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L
BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123
[TBL] [Abstract][Full Text] [Related]
17. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Emma F; Hoff WV; Hohenfellner K; Topaloglu R; Greco M; Ariceta G; Bettini C; Bockenhauer D; Veys K; Pape L; Hulton S; Collin S; Ozaltin F; Servais A; Deschênes G; Novo R; Bertholet-Thomas A; Oh J; Cornelissen E; Janssen M; Haffner D; Ravà L; Antignac C; Devuyst O; Niaudet P; Levtchenko E
Kidney Int; 2021 Nov; 100(5):1112-1123. PubMed ID: 34237326
[TBL] [Abstract][Full Text] [Related]
18. The gene therapy for corneal pathology with novel nonsense cystinosis mouse lines created by CRISPR Gene Editing.
Dong F; Amlal H; Venkatakrishnan J; Zhang J; Fry M; Yuan Y; Cheng YC; Hu YC; Kao WW
Ocul Surf; 2023 Jul; 29():432-443. PubMed ID: 37355021
[TBL] [Abstract][Full Text] [Related]
19. Cystinosis and two rare mutations in CTNS gene: two case reports.
Gholami Yarahmadi S; Sarlaki F; Morovvati S
J Med Case Rep; 2022 May; 16(1):181. PubMed ID: 35513889
[TBL] [Abstract][Full Text] [Related]
20. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis.
Cherqui S; Sevin C; Hamard G; Kalatzis V; Sich M; Pequignot MO; Gogat K; Abitbol M; Broyer M; Gubler MC; Antignac C
Mol Cell Biol; 2002 Nov; 22(21):7622-32. PubMed ID: 12370309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
